$LXRP ----


Interview aired yesterday.


Lexaria Bioscience (OTCQX:LXRP-CSE: LXX ) CEO Chris Bunka joined Steve Darling from Proactive with news the company has announced that its DehydraTECH technology significantly improved delivery in animal studies in use with representative drugs from two classes of antiviral therapies.

Chris Bunka tells Proactive what this step means for the company and where they plan on taking LXRP in 2021.


https://www.youtube.com/watch?v=tqtOIuIV8Ok